5 min listen
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
ratings:
Length:
5 minutes
Released:
Nov 16, 2023
Format:
Podcast episode
Description
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
Released:
Nov 16, 2023
Format:
Podcast episode
Titles in the series (99)
April 2, 2020 Issue Introduction by Neurology Today in 5